- Home
- KPLT vs RADX Comparison
KPLT vs RADX Comparison
Compare KPLT & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- RADX
- Stock Information
- Founded
- KPLT 2012
- RADX 2021
- Country
- KPLT United States
- RADX Australia
- Employees
- KPLT N/A
- RADX N/A
- Industry
- KPLT Diversified Commercial Services
- RADX
- Sector
- KPLT Consumer Discretionary
- RADX
- Exchange
- KPLT Nasdaq
- RADX NYSE
- Market Cap
- KPLT 35.6M
- RADX 32.5M
- IPO Year
- KPLT N/A
- RADX N/A
- Fundamental
- Price
- KPLT $9.00
- RADX $4.65
- Analyst Decision
- KPLT Hold
- RADX Strong Buy
- Analyst Count
- KPLT 2
- RADX 2
- Target Price
- KPLT $12.00
- RADX $13.50
- AVG Volume (30 Days)
- KPLT 53.1K
- RADX 16.7K
- Earning Date
- KPLT 05-15-2025
- RADX 02-26-2025
- Dividend Yield
- KPLT N/A
- RADX N/A
- EPS Growth
- KPLT N/A
- RADX N/A
- EPS
- KPLT N/A
- RADX N/A
- Revenue
- KPLT $254,079,000.00
- RADX $204,609.00
- Revenue This Year
- KPLT $20.12
- RADX N/A
- Revenue Next Year
- KPLT $13.19
- RADX N/A
- P/E Ratio
- KPLT N/A
- RADX N/A
- Revenue Growth
- KPLT 9.72
- RADX N/A
- 52 Week Low
- KPLT $5.08
- RADX $3.50
- 52 Week High
- KPLT $21.88
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- KPLT 60.14
- RADX N/A
- Support Level
- KPLT $8.22
- RADX N/A
- Resistance Level
- KPLT $9.11
- RADX N/A
- Average True Range (ATR)
- KPLT 0.77
- RADX 0.00
- MACD
- KPLT 0.19
- RADX 0.00
- Stochastic Oscillator
- KPLT 84.93
- RADX 0.00
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.